Stockscreener 앱 받기
2.56
1.59%
0.04
시간 외 거래:
2.70
0.14
+5.47%
Aclaris Therapeutics Inc 주식(ACRS)의 최신 뉴스
Will Aclaris Therapeutics Inc. stock outperform international peersTrade Ideas & Risk Managed Investment Entry Signals - newser.com
Key resistance and support levels for Aclaris Therapeutics Inc.2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Understanding Aclaris Therapeutics Inc.’s price movement2025 Top Gainers & High Yield Stock Recommendations - newser.com
Risk adjusted return profile for Aclaris Therapeutics Inc. analyzedWeekly Stock Report & Daily Profit Maximizing Tips - newser.com
Applying chart zones and confluence areas to Aclaris Therapeutics Inc.Dollar Strength & AI Enhanced Execution Alerts - newser.com
Will Aclaris Therapeutics Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - newser.com
Can Aclaris Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Statistical indicators supporting Aclaris Therapeutics Inc.’s strengthWatch List & Long Hold Capital Preservation Plans - newser.com
Why Aclaris Therapeutics Inc. (8AT) stock is a must watch tickerPortfolio Update Summary & AI Forecasted Stock Moves - newser.com
Why Aclaris Therapeutics Inc. (8AT) stock gets analyst attentionPortfolio Update Report & Proven Capital Preservation Methods - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock hit Wall Street targetsWeekly Profit Report & Fast Moving Stock Watchlists - newser.com
How Aclaris Therapeutics Inc. (8AT) stock performs during market turbulenceJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Will Aclaris Therapeutics Inc. benefit from macro trendsIndex Update & Stock Portfolio Risk Management - newser.com
Using Python tools to backtest Aclaris Therapeutics Inc. strategiesJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Why Aclaris Therapeutics Inc. stock attracts global investorsMarket Sentiment Review & Verified Momentum Watchlists - newser.com
Can you recover from losses in Aclaris Therapeutics Inc.Rate Cut & Safe Capital Growth Stock Tips - newser.com
Aclaris Therapeutics (NASDAQ:ACRS) adds US$40m to market cap in the past 7 days, though investors from three years ago are still down 83% - Yahoo Finance
How Aclaris Therapeutics Inc. stock trades before earningsWeekly Profit Report & Daily Stock Momentum Reports - newser.com
Is Aclaris Therapeutics Inc. stock a contrarian buy2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
How to use a screener to detect Aclaris Therapeutics Inc. breakoutsJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock a momentum leaderAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
What drives Aclaris Therapeutics Inc stock priceContrarian Investment Ideas & Investment Recommendations You Can Trust - earlytimes.in
Aclaris Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Will Aclaris Therapeutics Inc. (8AT) stock benefit from mergersQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Shares Climb 31% But Its Business Is Yet to Catch Up - 富途牛牛
Revenues Not Telling The Story For Aclaris Therapeutics, Inc. (NASDAQ:ACRS) After Shares Rise 31% - simplywall.st
Aclaris Therapeutics’ ATI-045 Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks
Will Aclaris Therapeutics Inc. stock outperform Dow Jones indexMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
0.64%
0.35%
자본화:
|
볼륨(24시간):